Description

The purpose of this Notice of Amendment is to announce the revised listing for Adrenocortical hormones to allow the nonprescription use of triamcinolone acetonide for the conditions listed below. Only the Human part of the PDL has been revised.

Resources

Name	Format	Description	Link
Notice - Prescription Drug List (PDL): Triamcinolone acetonide	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-triamcinolone-acetonide.html
Notice - Prescription Drug List (PDL): Triamcinolone acetonide	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-acetonide-triamcinolone.html

Tags

Topics

Categories